World Market for Over The Counter (OTC) Drugs, The

May 2012 | 190 pages | ID: W5D93AD759EEN
Kalorama Information

Abstracts

Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs. OTC drugs are sold to consumers by convenience and grocery stores. However, new technology has allowed a new range of outlets including online sales and catalog. Drugs included in OTC segments are pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product.

For the purpose of this study, Kalorama Information has divided products into five general segments:

• Analgesics
• Allergy, Cough, Cold, Flu Remedies
• Gastrointestinal Remedies
• Dermatologics
• Others, including:
  • Smoking cessation products
  • Sleepaids
  • Hair growth remedies
  • Diet aids

Revenues for each segment were generated using dollar and unit sales for key products in each segment and region. The report provides examples of OTC drugs in each general region, segmented as follows:

• Asia Pacific and Africa
• Europe
• North America
• South America

The report includes incidence of conditions which are often treated with OTC medicines, health statistics related to the industry, birth rates, world population, populations by region and issues affecting the market as a whole. Information is presented as a worldwide overview, with special emphasis on the U.S., Japan, Germany, and other key markets. The market segments provide an overview of demographics, overview of products available in each region, market estimates and forecasts. Additionally, a competitive analysis of leading providers and profiles of providers is covered.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2011. Historical data was provided for the years 2007 through 2010, with forecast data provided for 2012 through 2015. Compound annual growth rates (CAGRs) are provided for the 2007-2011 and 2011-2015 periods for each region and/or segment covered. Competitive analysis is provided for the year 2011 with some reference for 2009 and 2010. The forecasted market analysis for 2011-2015 was largely based on demographic trends, new developments, and global expansion.

Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Background
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting Market
Leading Competitors

CHAPTER TWO: INTRODUCTION

Background
Distribution and Safety Issues in the United States
Consumer Advertising/Promotion
World Health and Life Expectancy
  Life Expectancy
  Birth Rates
  Tobacco Use
  Obesity
Declining Growth of the World Population
Prescription vs. Over-the-Counter Industry
  Rx-to-OTC Switch Industry
  Rx-to-OTC Switch Forecast in the United States
Economic Trends
  Purchasing Power Trends
  U.S. Healthcare Market
  U.S. Healthcare Challenges
Health Insurance Issues and Trends
  Healthcare Flexible Spending Accounts and OTC Medicines
Consumer Issues and Trends
  U.S Consumers
  Consumers Around the World
Access to Professional Medical Services and the Link to Self-Medication
  Online Resources for Health Information
Regulatory Environment
  Revisions to Pharmaceutical Affairs Law (PAL) in Japan
  Russian Beneficiary Drug Provision Program
  A Third Class of Drugs in the United States

CHAPTER THREE: OTC MARKETS IN ASIA-PACIFIC AND AFRICA

Overview
Demographics
OTC Product Segments
Market Analysis
  OTC Product Segment Market Analysis
  Markets by Country

CHAPTER FOUR: OTC MARKETS IN EUROPE

Overview
Demographics
OTC Product Segments
Market Analysis
  OTC Product Segment Market Analysis
  Markets by Country

CHAPTER FIVE: OTC MARKETS IN NORTH AMERICA

Overview
Demographics
OTC Product Segments
Market Analysis
  OTC Product Segment Market Analysis
  Markets by Country

CHAPTER SIX: OTC MARKETS IN SOUTH AMERICA

Overview
Demographics
OTC Product Segments
Market Analysis
  OTC Product Segment Market Analysis
  Markets by Country

CHAPTER SEVEN: SUMMARY OF WORLD OTC MARKETS

Overview
  OTC Product Segment Market Analysis
  Markets by Country

CHAPTER EIGHT: LEADING OTC MANUFACTURERS

Overview
Competitor Analysis
Significant Agreements, Mergers and Acquisitions
  Procter & Gamble and Teva Pharmaceutical Industries
  Sanofi and Chattem Consumer
  Schering-Plough and Merck & Co.
  Wyeth and Pfizer
  Reckitt Benckiser and Adams Respiratory Therapeutics
  Bristol-Myers Squibb and Novartis AG
  Johnson & Johnson and Pfizer
  Reckitt Benckiser and Boots Healthcare
  Bayer and Roche
Leading Corporate Profiles
  Bayer Healthcare Ag
  Boehringer Ingelheim Gmbh
  Glaxosmithkline
  Mc Neil Consumer
  (A Johnson & Johnson Company)
  Merck
  Novartis Consumer
  Pfizer
  Procter & Gamble
  Reckitt Benckiser
  Sanofi
  Taisho Pharmaceutical
APPENDIX: LIST OF MAJOR COMPANIES